Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study
The results of this study have the potential to empower our knowledge of variability in patient response to sulfonylureas, and carry significant implications for advancing precision medicine in type 2 diabetes management.
Authors
- Sara S. Bashraheel (ORCID: https://orcid.org/0000-0003-0672-9698)
- Mohamed A. Elrayess (ORCID: https://orcid.org/0000-0003-3803-4604)
- Khaled Naja (ORCID: https://orcid.org/0000-0001-9259-3082)
- Najeha Anwardeen (ORCID: https://orcid.org/0000-0002-7263-4905)
Institutions
- Qatar University (QA)
Publication Details
- Journal
- Journal of Pharmacy & Pharmaceutical Sciences
- Published
- 2024-09-17
- DOI
- https://doi.org/10.3389/jpps.2024.13305
- Citations
- 4
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94